The Motley Fool’s Simon Erickson talks with Sean O’Reilly about what he learned at the SXSW Conference.

Thanks to Away for supporting Motley Fool. Go to awaytravel.com/fool and use the promo code fool to get $20 off your order!

Artificial intelligence and gene sequencing are changing how patients are treated. Analyst Simon Erickson shares some of the greatest opportunities and some of the biggest hurdles to adoption of the latest technology in healthcare.

Thanks to Away for supporting Motley Fool. Go to awaytravel.com/fool and use the promo code fool to get $20 off your order!

For the leading streaming service and global entertainment giant, product testing is always happening behind the scenes. Tune in to find out how both companies leverage various tools at their disposal to put forward the “perfect” customer experience.

Thanks to Away for supporting the Motley Fool. Go to awaytravel.com/fool and use the promo code “fool” to get $20 off your order!

Apparently Snap's IPO has a lot of people thinking about shorting stocks -- we answer a listener question and get into the nitty gritty risks of deciding to go short.

Here's why  Exelixis, Pacira Pharmaceuticals, Kite Pharma, Exact Sciences, and Portola Pharmaceuticals are up more than 50% in the first two months of 2017. 

Based on the latest network quality reports, most consumers will be happy with any of the Big Four wireless carriers, but one company continues to shake up the industry. We also provide an update on the struggle Bass Pro Shops is facing in its $4.5 deal with Cabela’s, before looking at the growing trend of delivery as a differentiator for restaurants.

The Oracle of Omaha just released his latest letter to the shareholders of Berkshire Hathaway. In this episode of Industry Focus, we talk about what he had to say. 

Snap's IPO went well, and the stock is flying high, but that hasn't changed our minds about the ephemeral messaging app/camera company.